Cargando…

Congenital adrenal hyperplasia patient perception of ‘disorders of sex development’ nomenclature

BACKGROUND: As the benefits of patient-centered care have become more widely recognized, it is important to understand patients’ sentiments regarding aspects affecting their care. In an effort to display more sensitivity to patient concerns, the term “disorders of sex development” (DSD) was proposed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin-Su, Karen, Lekarev, Oksana, Poppas, Dix P, Vogiatzi, Maria G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360949/
https://www.ncbi.nlm.nih.gov/pubmed/25780368
http://dx.doi.org/10.1186/s13633-015-0004-4
_version_ 1782361601834221568
author Lin-Su, Karen
Lekarev, Oksana
Poppas, Dix P
Vogiatzi, Maria G
author_facet Lin-Su, Karen
Lekarev, Oksana
Poppas, Dix P
Vogiatzi, Maria G
author_sort Lin-Su, Karen
collection PubMed
description BACKGROUND: As the benefits of patient-centered care have become more widely recognized, it is important to understand patients’ sentiments regarding aspects affecting their care. In an effort to display more sensitivity to patient concerns, the term “disorders of sex development” (DSD) was proposed in 2006 as new nomenclature to replace older terms that were considered to have negative connotations. METHODS: The objective of the study was to examine the views of congenital adrenal hyperplasia (CAH) patients and their caregivers regarding the new nomenclature. The study was observational to evaluate the views of the CAH community, and the primary endpoint was perception of the term DSD. The study was conducted as a survey about views regarding DSD nomenclature. The survey was sent via email to eligible subjects. Along with a short introduction explaining the term DSD, the survey was sent to eligible CAH patients and their caregivers. 589 CAH patients or family members participated in the survey. RESULTS: A total of 589 responses were received (255 classical females, 104 non-classical females, 174 males, 56 not specified) (547 U.S., 42 international) (128 CAH patients, 408 parents or other family members). 70.6% had never heard the term DSD. 71.0% disliked or strongly disliked the term DSD. 83.6% stated they did not identify with the term DSD. 76.0% felt that the term DSD has a negative effect on the CAH community. There was no significant difference in opinion of DSD between classical females and other CAH patients, between US and international, between surgical and non-surgical patients, or between patients and parents. There was no correlation with patient age. CONCLUSIONS: Our results indicate that the majority of parents and patients with CAH are dissatisfied with the term DSD. Our results highlight the challenges within the field of DSD to reach a consensus regarding a sensitive topic and to bridge the gap between current medical practice and patient satisfaction. It is the authors’ belief that reconsideration of the current nomenclature and ongoing dialogue between the medical community and patients will eventually lead to removal of stigmatization, better management protocols, and improved outcomes.
format Online
Article
Text
id pubmed-4360949
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43609492015-03-17 Congenital adrenal hyperplasia patient perception of ‘disorders of sex development’ nomenclature Lin-Su, Karen Lekarev, Oksana Poppas, Dix P Vogiatzi, Maria G Int J Pediatr Endocrinol Research BACKGROUND: As the benefits of patient-centered care have become more widely recognized, it is important to understand patients’ sentiments regarding aspects affecting their care. In an effort to display more sensitivity to patient concerns, the term “disorders of sex development” (DSD) was proposed in 2006 as new nomenclature to replace older terms that were considered to have negative connotations. METHODS: The objective of the study was to examine the views of congenital adrenal hyperplasia (CAH) patients and their caregivers regarding the new nomenclature. The study was observational to evaluate the views of the CAH community, and the primary endpoint was perception of the term DSD. The study was conducted as a survey about views regarding DSD nomenclature. The survey was sent via email to eligible subjects. Along with a short introduction explaining the term DSD, the survey was sent to eligible CAH patients and their caregivers. 589 CAH patients or family members participated in the survey. RESULTS: A total of 589 responses were received (255 classical females, 104 non-classical females, 174 males, 56 not specified) (547 U.S., 42 international) (128 CAH patients, 408 parents or other family members). 70.6% had never heard the term DSD. 71.0% disliked or strongly disliked the term DSD. 83.6% stated they did not identify with the term DSD. 76.0% felt that the term DSD has a negative effect on the CAH community. There was no significant difference in opinion of DSD between classical females and other CAH patients, between US and international, between surgical and non-surgical patients, or between patients and parents. There was no correlation with patient age. CONCLUSIONS: Our results indicate that the majority of parents and patients with CAH are dissatisfied with the term DSD. Our results highlight the challenges within the field of DSD to reach a consensus regarding a sensitive topic and to bridge the gap between current medical practice and patient satisfaction. It is the authors’ belief that reconsideration of the current nomenclature and ongoing dialogue between the medical community and patients will eventually lead to removal of stigmatization, better management protocols, and improved outcomes. BioMed Central 2015-03-16 2015 /pmc/articles/PMC4360949/ /pubmed/25780368 http://dx.doi.org/10.1186/s13633-015-0004-4 Text en © Lin-Su et al.; licensee Biomed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lin-Su, Karen
Lekarev, Oksana
Poppas, Dix P
Vogiatzi, Maria G
Congenital adrenal hyperplasia patient perception of ‘disorders of sex development’ nomenclature
title Congenital adrenal hyperplasia patient perception of ‘disorders of sex development’ nomenclature
title_full Congenital adrenal hyperplasia patient perception of ‘disorders of sex development’ nomenclature
title_fullStr Congenital adrenal hyperplasia patient perception of ‘disorders of sex development’ nomenclature
title_full_unstemmed Congenital adrenal hyperplasia patient perception of ‘disorders of sex development’ nomenclature
title_short Congenital adrenal hyperplasia patient perception of ‘disorders of sex development’ nomenclature
title_sort congenital adrenal hyperplasia patient perception of ‘disorders of sex development’ nomenclature
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360949/
https://www.ncbi.nlm.nih.gov/pubmed/25780368
http://dx.doi.org/10.1186/s13633-015-0004-4
work_keys_str_mv AT linsukaren congenitaladrenalhyperplasiapatientperceptionofdisordersofsexdevelopmentnomenclature
AT lekarevoksana congenitaladrenalhyperplasiapatientperceptionofdisordersofsexdevelopmentnomenclature
AT poppasdixp congenitaladrenalhyperplasiapatientperceptionofdisordersofsexdevelopmentnomenclature
AT vogiatzimariag congenitaladrenalhyperplasiapatientperceptionofdisordersofsexdevelopmentnomenclature